Headaches and Insomnia Going Hand in Hand

Headaches and Insomnia Going Hand in Hand

Sepracor Pharmaceuticals Ltd Withdraws Its Marketing Authorisation Application For Lunivia (eszopiclone)
The European Medicines Agency has been formally notified by Sepracor Pharmaceuticals Ltd of its decision to withdraw its application for a centralised marketing authorisation for the medicine Lunivia (eszopiclone), 2 and 3 mg tablets. Lunivia was expected to be used for the treatment of insomnia, including difficulty falling asleep, nocturnal awakening or early awakening in adults, usually for short-term duration.

Combination Therapy Appears Helpful For Short-Term Treatment Of Insomnia; Cognitive Behavior Therapy May Be Better For Long-Term
For patients with persistent insomnia, a combination of cognitive behavior therapy (CBT) and the medication zolpidem for 6 weeks was associated with improvement in sleep, although for a longer treatment period CBT alone was more beneficial, according to a study in the May 20 issue of JAMA. Insomnia is a prevalent public health problem affecting large segments of the population on a situational, recurrent, or chronic basis.

Sleeping Through Dialysis: No Nightmare For Kidney Patients
Dialysis takes hours of kidney disease patients' time several days a week, so why not do it at night while sleeping? Overnight dialysis is more convenient for some patients and offers significant benefits over shorter daytime treatments, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).

Testing New Fluorescent Lighting For Synchronizing Older Patients' Sleep-Wake Cycles
Change the lighting; improve your health.

The (Un)Lucky Snorers Burn More Calories

Chronic Insomnia Treated Effectively By Online Cognitive Behavioral Therapy
A study in the June 1 issue of the journal SLEEP demonstrates that online cognitive behavioral therapy (CBT) for chronic insomnia significantly improves insomnia severity, daytime fatigue, and sleep quality. Online treatment also reduces erroneous beliefs about sleep and pre-sleep mental arousal.

CardioNet Announces Launch Of Clinical Indicator For Sleep Disorders

CardioNet Announces Launch Of Clinical Indicator For Sleep Disorders
CardioNet, Inc. (NASDAQ:BEAT) announced the launch of SomNet ™, a new clinical indicator available in the Company's existing Mobile Cardiac Outpatient Telemetry™ (MCOT™) system.

Health Tip: Prevent Burnout
Title: Health Tip: Prevent Burnout
Category: Health News
Created: 5/11/2009 9:27:00 AM
Last Editorial Review: 5/11/2009

Surgery, Oral Devices Associated With Improvement In Sleep Breathing Disorder
Treatment with surgery or an oral appliance that adjusts the jaw is associated with improvements in obstructive sleep apnea, a condition caused by blocked upper airways in which patients periodically stop breathing during sleep, according to two reports in the May issue of Archives of Otolaryngology-Head & Neck Surgery, one of the JAMA/Archives journals.

Trouble Keeping Up with Your CPAP?

Pills Plus Psychotherapy Can Beat Insomnia
Title: Pills Plus Psychotherapy Can Beat Insomnia
Category: Health News
Created: 5/20/2009 2:00:00 AM
Last Editorial Review: 5/20/2009

Sepracor Pharmaceuticals Ltd Withdraws Its Marketing Authorisation Application For Lunivia (eszopiclone)
The European Medicines Agency has been formally notified by Sepracor Pharmaceuticals Ltd of its decision to withdraw its application for a centralised marketing authorisation for the medicine Lunivia (eszopiclone), 2 and 3 mg tablets. Lunivia was expected to be used for the treatment of insomnia, including difficulty falling asleep, nocturnal awakening or early awakening in adults, usually for short-term duration.